These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Screening capacity and cost-effectiveness of the human papillomavirus test versus cervicography as an adjunctive test to Pap cytology to detect high-grade cervical dysplasia. Song T, Seong SJ, Lee SK, Kim BR, Ju W, Kim KH, Nam K, Sim JC, Kim TJ. Eur J Obstet Gynecol Reprod Biol; 2019 Mar; 234():112-116. PubMed ID: 30682600 [Abstract] [Full Text] [Related]
4. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial. Lazcano-Ponce E, Lorincz AT, Cruz-Valdez A, Salmerón J, Uribe P, Velasco-Mondragón E, Nevarez PH, Acosta RD, Hernández-Avila M. Lancet; 2011 Nov 26; 378(9806):1868-73. PubMed ID: 22051739 [Abstract] [Full Text] [Related]
5. Randomized controlled trial of human papillomavirus testing versus Pap cytology in the primary screening for cervical cancer precursors: design, methods and preliminary accrual results of the Canadian cervical cancer screening trial (CCCaST). Mayrand MH, Duarte-Franco E, Coutlée F, Rodrigues I, Walter SD, Ratnam S, Franco EL, CCCaST Study Group. Int J Cancer; 2006 Aug 01; 119(3):615-23. PubMed ID: 16572425 [Abstract] [Full Text] [Related]
8. Primary HPV testing: a proposal for co-testing in initial rounds of screening to optimise sensitivity of cervical cancer screening. Herbert A. Cytopathology; 2017 Feb 01; 28(1):9-15. PubMed ID: 27005867 [Abstract] [Full Text] [Related]
10. Detection of human papillomavirus DNA in routine cervical scraping samples: use for a national cervical cancer screening program in a developing nation. Othman N, Othman NH. Asian Pac J Cancer Prev; 2014 Feb 01; 15(5):2245-9. PubMed ID: 24716964 [Abstract] [Full Text] [Related]
12. Comparison of HPV test versus conventional and automation-assisted Pap screening as potential screening tools for preventing cervical cancer. Nieminen P, Vuorma S, Viikki M, Hakama M, Anttila A. BJOG; 2004 Aug 01; 111(8):842-8. PubMed ID: 15270934 [Abstract] [Full Text] [Related]
13. Risk assessment to guide cervical screening strategies in a large Chinese population. Zhao FH, Hu SY, Zhang Q, Zhang X, Pan QJ, Zhang WH, Gage JC, Wentzensen N, Castle PE, Qiao YL, Katki HA, Schiffman M. Int J Cancer; 2016 Jun 01; 138(11):2639-47. PubMed ID: 26800481 [Abstract] [Full Text] [Related]
14. [Relation of cervical cancer with the results of human papillomavirus (HPV) screening carried out via hybrid capture 2 method on 52.000 women in Erzurum]. Göktuğ Kadıoğlu B, Çınar Tanrıverdi E, Alay H, Uçar M. Mikrobiyol Bul; 2018 Oct 01; 52(4):367-375. PubMed ID: 30522422 [Abstract] [Full Text] [Related]
16. HPV DNA testing with cytology triage in cervical cancer screening: Influence of revealing HPV infection status. Richardson LA, El-Zein M, Ramanakumar AV, Ratnam S, Sangwa-Lugoma G, Longatto-Filho A, Cardoso MA, Coutlée F, Franco EL, PEACHS (Pap Efficacy After Cervical HPV Status) Study Consortium. Cancer Cytopathol; 2015 Dec 01; 123(12):745-54. PubMed ID: 26230283 [Abstract] [Full Text] [Related]
18. Comparison of initial stream urine samples and cervical samples for detection of human papillomavirus. Hagihara M, Yamagishi Y, Izumi K, Miyazaki N, Suzuki T, Kato H, Nishiyama N, Koizumi Y, Suematsu H, Mikamo H. J Infect Chemother; 2016 Aug 01; 22(8):559-62. PubMed ID: 27342077 [Abstract] [Full Text] [Related]
19. Human papillomavirus testing for primary cervical cancer screening. Grce M, Davies P. Expert Rev Mol Diagn; 2008 Sep 01; 8(5):599-605. PubMed ID: 18785808 [Abstract] [Full Text] [Related]
20. Cervicography and HPV DNA testing as triage criteria for patients with abnormal pap smear. Costa S, Sideri M, Bucchi L, Schettino F, Maini I, Spinaci L, Bovicelli L, Terzano P. Gynecol Oncol; 1998 Dec 01; 71(3):404-9. PubMed ID: 9887239 [Abstract] [Full Text] [Related] Page: [Next] [New Search]